Standard Biotools (LAB) Net Income towards Common Stockholders (QoQ) (2010 - 2026)
Standard Biotools (LAB) Net Income towards Common Stockholders (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.93 Bn | 193.33 Bn | 7.27 Bn |
| 2 | Stryker | 128.56 Bn | 125.08 Bn | 4.50 Bn |
| 3 | Medtronic | 119.26 Bn | 110.04 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.35 Bn | 72.81 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.06 Bn | 47.81 Bn | 1.35 Bn |
| 6 | Dexcom | 34.55 Bn | 32.61 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.39 Bn | 23.07 Bn | 4.55 Bn |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn |
| 10 | Standard Biotools | 254.39 Mn | -222.33 Mn | 10.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -103.69% |
| Mar 31, 2026 | 6,632.69% |
| Dec 31, 2025 | 93.75% |
| Sep 30, 2025 | -96.27% |
| Jun 30, 2025 | -563.65% |
| Mar 31, 2025 | -119.19% |
| Dec 31, 2024 | 163.30% |
| Sep 30, 2024 | 13.85% |
| Jun 30, 2024 | 20.81% |
| Mar 31, 2024 | -327.45% |
| Dec 31, 2023 | 167.12% |
| Sep 30, 2023 | -23.52% |
| Jun 30, 2023 | -1.16% |
| Mar 31, 2023 | -110.99% |
| Dec 31, 2022 | 620.61% |
| Sep 30, 2022 | 53.70% |
| Jun 30, 2022 | 16.69% |
| Sep 30, 2021 | -38.57% |
| Jun 30, 2021 | -91.32% |
| Mar 31, 2021 | -4.06% |